Abstract:Currently, liver cancer is the sixth most prevalent cancer and the third most common cause of cancer-related death. However, effective chemotherapeutic drugs with low drug resistance and few side-effects for the clinical treatment of liver cancer are lacking. Therefore, the search for novel drugs to compensate for the defects of existing drugs is urgently needed. Herein, we successfully screened an extract named from Stellera chamaejasme L. (SCL), a historically confimed antitumor plant, through a novel extraction platform. In the present study, we firstly screened the anticancer effect of ESC by the sulforhodamine B (SRB) cell proliferation assay in a wide range of malignant cell lines, including A549, NCI-H157, NCI-H460, SK-HEP-1 and HepG2. With the highest inhibitory rate in hepatocarcinoma cells, we further identified the tumor-suppressive efficacy and the safety of ESC in an H22 hepatocarcinoma xenograft model in vivo. In a mechanistic study, flow cytometry and western blot analysis were performed to evaluate the effects of ESC on the induction of cell apoptosis, intervention of cell cycle distribution and its influence on key G2/M-phase regulators. The results showed that ESC significantly inhibited the cell growth of liver cancer cell lines. Accordingly, the tumor inhibition rate was also increased following ESC administration with little systemic toxicity in H22-transplanted mice. Mechanistically, ESC caused obvious G2/M-phase arrest in both the SK-HEP-1 and HepG2 cell lines without cell apoptosis. Furthermore, cyclin B1 was downregulated, while the phosphorylation level of CDK1 was increased in response to ESC treatment. All these data confirmed that ESC possesses potent anti-proliferative efficacy for hepatocarcinoma through the induction of cyclin-mediated cell cycle arrest. Thus, ESC is a promising candidate for hepatocarcinoma treatment in the future.

(24S)-Ergostane-3β,5α,6β-triol from Hedyotis Chrysotricha with Inhibitory Activity on Migration of SK-HEP-1 Human Hepatocarcinoma Cells.

Synthesis and Antitumor Activity of Hederagenin Derivatives

Cytotoxic And Apoptosis-Inducing Activity Of Triterpene Glycosides From Holothuria Scabra And Cucumaria Frondosa Against Hepg2 Cells

Isolation and Characterization of Methyl Esters and Derivatives from Euphorbia Kansui (euphorbiaceae) and Their Inhibitory Effects on the Human Sgc-7901 Cells.

In Vitro Anti-Cancer Activity of Chamaejasmenin B and Neochamaejasmin C Isolated from the Root of Stellera Chamaejasme L

Cytotoxic cholestane-type and ergostane-type steroids from the aerial parts of Euphorbia altotibetic.

Evaluating the Potential Bioactivity of a Novel Compound ER1626.

Daphnane-type diterpenoids from Stellera chamaejasme L. and their inhibitory activity against hepatocellular carcinoma cells

Hepatocellular Carcinoma Growth is Inhibited Byeuphorbia Helioscopial. Extract in Nude Mice Xenografts

Inhibitory Effects Of Tumor Cell Metastasis By Sulfated Triterpene Glycosides, Echinoside A, 24-Dehydroechinoside A And Holothurin A(1), Derived From Sea Cucumber

A novel cell cycle blocker extracted from Stellera chamaejasme L. inhibits the proliferation of hepatocarcinoma cells.

Bioactive C21 Steroidal Glycosides from Euphorbia kansui Promoted HepG2 Cell Apoptosis via the Degradation of ATP1A1 and Inhibited Macrophage Polarization under Co-Cultivation

Screening of anti-tumor active sites of Heliciopsis lobata

Synthesis of 3′-Methoxy-e-diethylstilbestrol and Its Analogs As Tumor Angiogenesis Inhibitors

Anticancer Potential of Euphorbia helioscopia L Extracts Against Human Cancer Cells

New guaiane-type sesquiterpenoid dimers from Artemisia atrovirens and their antihepatoma activity

Cytotoxic Activities of Some Selected Medicinal Plants of the Genus Euphorbia

Cytotoxic steroids from Polyporus umbellatus.

Triterpenoids, steroids and other constituents from Euphorbia kansui and their anti-inflammatory and anti-tumor properties

The Cytotoxic Activity and Metabolic Profiling of Hyptis rhomboidea Mart. et Gal

N-butanol Fraction of Entada Phaseoloides Ethanol Extract Inhibits Hepatocellular Carcinoma HepG2 Cell Proliferation by Inducing Apoptosis.